Showing results (1-10 of 79) with videos related to
Sort By:
Pageof 8
Kidney International|March 4, 2014
Are serum suPAR determinations by current ELISA methodology reliable diagnostic biomarkers for FSGS?Detlef SchlöndorffJournal of the American Society of Nephrology : JASN|May 28, 2009
The mesangial cell revisited: no cell is an islandDetlef Schlöndorff, Bernhard BanasSeminars in Nephrology|May 30, 2007
Role of chemokines for the localization of leukocyte subsets in the kidneyStephan Segerer, Detlef SchlöndorffCurrent Opinion in Nephrology and Hypertension|April 11, 2007
Toll-like receptors: emerging concepts in kidney diseaseHans-Joachim Anders, Detlef SchlöndorffJournal of the American Society of Nephrology : JASN|January 5, 2000
Chemokines, chemokine receptors, and renal disease: from basic science to pathophysiologic and therapeutic studiesStephan Segerer, Peter J Nelson, Detlef SchlöndorffSeminars in Nephrology|March 6, 2007
Chemokines and chemokine receptors as therapeutic targets in lupus nephritisVolker Vielhauer, Hans-Joachim Anders, Detlef SchlöndorffNephrologie & Therapeutique|December 23, 2006
[Microbial nucleic acids in the pathogenesis of glomerulonephritis]Hans-Joachim Anders, Daniel Zecher, Detlef SchlöndorffJournal of the American Society of Nephrology : JASN|March 23, 2004
Signaling danger: toll-like receptors and their potential roles in kidney diseaseHans-Joachim Anders, Bernhard Banas, Detlef SchlöndorffKidney International|March 13, 2003
Chemokines and chemokine receptors are involved in the resolution or progression of renal diseaseHans-Joachim Anders, Volker Vielhauer, Detlef SchlöndorffEuropean Journal of Immunology|February 16, 2006
Differential mechanisms of microparticle transfer toB cells and monocytes: anti-inflammatory propertiesof microparticlesBarbara Köppler, Clemens Cohen, Detlef Schlöndorff, et al.Pageof 8